Grey Wolf Animal Health Corp. (TSXV:WOLF)

Market Cap	33.51M
Revenue (ttm)	28.70M
Net Income (ttm)	605.84K
Shares Out	34.19M
EPS (ttm)	0.02
PE Ratio	56.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8,175
Open	0.9700
Previous Close	0.9700
Day's Range	0.9700 - 0.9700
52-Week Range	0.6000 - 1.2000
Beta	0.35
RSI	63.40
Earnings Date	May 21, 2025

About Grey Wolf Animal Health

Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. The company operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics. It provides pharmaceuticals, which includes sedaject, ataject, and thyro-tabs canine drugs; and wound care products, including medical tubes, viscose net dressings, alginate dressing, absorbent foam dressing, elastic b...

• Industry: Personal Services
• Sector: Consumer Discretionary
• CEO: Angela Cechetto
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: WOLF

Financial Performance

In 2024, Grey Wolf Animal Health's revenue was 26.83 million, an increase of 5.58% compared to the previous year's 25.41 million. Earnings were 704,668, an increase of 15.60%.